Skip to content
GARDP Logo
Menu
  • About GARDP
    • Vision & Mission
    • DNDi-WHO initiative
    • Partnerships
    • Donors
    • Governance
    • GARDP team
    • Jobs
    • Request for proposals
    • Contact us
    • Close
  • R&D strategy
    • Prioritization process to guide R&D
    • Portfolio selection process
    • Sustainable access
    • 5BY25
    • Close
  • Programmes
    • Sexually-transmitted infections
    • Neonatal sepsis
    • Paediatric antibiotics
    • Antimicrobial memory recovery, evaluation and exploratory research
    • Close
  • News & Resources
    • Press releases
    • In the media
    • Updates
    • Events
    • Publications & reports
    • Scientific articles
    • Blogs
    • Close
    • Close
  • Home
  • News & resources
  • In the media

In the media

ET Health World [5 February 2019]

“Standardised surveillance of HAIs is the need of the hour: Dr Ganesh Madhu”

Click here to read the article

In the mediaNeonatal Sepsis

Post navigation

Previous
Time: “Justin Trudeau, Jane Goodall and others on their big ideas for changing the 2020s”
Next
Wired: “Inside the disgustingly gloopy fight against super-gonorrhoea”
  • News & resources
  • Press releases
    • Press Releases – Other Languages
    • 2019
    • 2018
    • 2017
    • 2016
  • In the media
    • 2019
    • 2018
    • 2017
    • 2016
  • Updates
  • Events
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Publications & reports
  • Scientific articles
    • 2019
    • 2018
    • 2017
  • Blog

About GARDP

Launched in 2016 by WHO and DNDi, the Global Antibiotic Research & Development Partnership (GARDP) aims to develop and deliver new treatments for bacterial infections where drug resistance is present or emerging, or for which inadequate treatment exists, while endeavouring to ensure sustainable access.

DNDi LogoWHO Logo

 

  • PRIVACY POLICY
  • TERMS OF USE
  • ACCEPTABLE USE POLICY
  • COOKIE POLICY

© Drugs for Neglected Diseases initiative (DNDi)

Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License

We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser. Read cookie policy. Close